Literature DB >> 19673982

Validation of the Clinical COPD Questionnaire as a psychophysical outcome measure in adult laryngotracheal stenosis.

S A R Nouraei1, P S Randhawa, E F Koury, A Abdelrahim, C R Butler, A Venkataraman, D J Howard, G S Sandhu.   

Abstract

OBJECTIVES: To validate the Clinical Chronic Obstructive Pulmonary Disease Questionnaire (CCQ), a patient-administered instrument developed for bronchopulmonary disease as a disease-specific psychophysical outcome measure for adult laryngotracheal stenosis.
DESIGN: Prospective observational study. SETTINGS: Tertiary/National referral airway reconstruction centre. PARTICIPANTS: Thirty-three tracheostomy-free patients undergoing endoscopic laryngotracheoplasty. MAIN OUTCOME MEASURES: CCQ and the Medical Research Council (MRC) Dyspnoea scale, a previously validated but more limited scale, were administered to patients 2 weeks before surgery, preoperatively, and 2 weeks after endoscopic laryngotracheoplasty. Pulmonary function was assessed preoperatively. Internal consistency was assessed with Cronbach alpha statistics and test-retest reliability was determined using intraclass correlation. Correlations between CCQ and MRC scale, and pulmonary function were used to assess convergent and divergent validity respectively. Instrument responsiveness was assessed by correlating total and domain-specific CCQ scores with anatomical disease severity and post-treatment effect size.
RESULTS: There were 12 males and 21 females. Mean age was 44 +/- 15 years. Cronbach alpha coefficient and intraclass correlation coefficient were 0.88 and 0.95 respectively. Total and domain-specific CCQ scores significantly correlated with the MRC scores (P < 0.001) and significant correlations between CCQ and peak expiratory flow rate and FEV(1) were identified (P < 0.03). There were statistically significant changes in total and domain-specific CCQ scores when different stenosis severities were compared. Clinical COPD Questionnaire scores also changed significantly and congruently following surgery (P < 0.05 in both cases). DISCUSSION: Clinical COPD Questionnaire is a valid and sensitive instrument for assessing symptom severity and levels of function and well-being in adult patients with laryngotracheal stenosis and can be used as a patient-centred disease-specific outcome measure for this condition.

Entities:  

Mesh:

Year:  2009        PMID: 19673982     DOI: 10.1111/j.1749-4486.2009.01969.x

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  13 in total

Review 1.  Patient-Reported Outcome Measures in Upper Airway-Related Dyspnea: A Systematic Review.

Authors:  Meaghan Noud; Kristen Hovis; Alexander Gelbard; Nila A Sathe; David F Penson; Irene D Feurer; Melissa L McPheeters; David O Francis
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-08-01       Impact factor: 6.223

2.  Evaluation of Dyspnea Outcomes After Endoscopic Airway Surgery for Laryngotracheal Stenosis.

Authors:  Idris Samad; Lee Akst; Selmin Karatayli-Özgürsoy; Kristine Teets; Marissa Simpson; Ashwyn Sharma; Simon R A Best; Alexander T Hillel
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-11-01       Impact factor: 6.223

3.  Health Care Costs and Cost-effectiveness in Laryngotracheal Stenosis.

Authors:  Linda X Yin; William V Padula; Shekhar Gadkaree; Kevin Motz; Sabrina Rahman; Zachary Predmore; Alexander Gelbard; Alexander T Hillel
Journal:  Otolaryngol Head Neck Surg       Date:  2018-11-27       Impact factor: 3.497

4.  Feasibility of vocal fold abduction and adduction assessment using cine-MRI.

Authors:  Marina Mat Baki; Alex Menys; David Atkinson; Paul Bassett; Simon Morley; Timothy Beale; Guri Sandhu; Georgekutty Naduvilethil; Nicola Stevenson; Martin A Birchall; Shonit Punwani
Journal:  Eur Radiol       Date:  2016-04-16       Impact factor: 5.315

5.  Early medical therapy for acute laryngeal injury (ALgI) following endotracheal intubation: a protocol for a prospective single-centre randomised controlled trial.

Authors:  Anne S Lowery; Kyle Kimura; Justin Shinn; Chevis Shannon; Alexander Gelbard
Journal:  BMJ Open       Date:  2019-07-27       Impact factor: 2.692

6.  Incidence and Outcomes of Acute Laryngeal Injury After Prolonged Mechanical Ventilation.

Authors:  Justin R Shinn; Kyle S Kimura; Benjamin R Campbell; Anne Sun Lowery; Christopher T Wootten; C Gaelyn Garrett; David O Francis; Alexander T Hillel; Liping Du; Jonathan D Casey; E Wesley Ely; Alexander Gelbard
Journal:  Crit Care Med       Date:  2019-12       Impact factor: 7.598

7.  Impact of Adjuvant Medical Therapies on Surgical Outcomes in Idiopathic Subglottic Stenosis.

Authors:  Matthew R Hoffman; Ankita Patro; Li-Ching Huang; Sheau-Chiann Chen; Lynn D Berry; Alexander Gelbard; David O Francis
Journal:  Laryngoscope       Date:  2021-06-12       Impact factor: 3.325

8.  Endoscopic Resection and Mucosal Reconstitution With Epidermal Grafting: A Pilot Study in Idiopathic Subglottic Stenosis.

Authors:  Ruth J Davis; Ioan Lina; Kevin Motz; Alexander Gelbard; Robert R Lorenz; Guri S Sandhu; Alexander T Hillel
Journal:  Otolaryngol Head Neck Surg       Date:  2021-07-13       Impact factor: 5.591

9.  Health status in patients with coexistent COPD and heart failure: a validation and comparison between the Clinical COPD Questionnaire and the Minnesota Living with Heart Failure Questionnaire.

Authors:  Farida F Berkhof; Leola Metzemaekers; Steven M Uil; Huib A M Kerstjens; Jan W K van den Berg
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-09-22

10.  Treatment options in idiopathic subglottic stenosis: protocol for a prospective international multicentre pragmatic trial.

Authors:  Alexander Gelbard; Yu Shyr; Lynne Berry; Alexander T Hillel; Dale C Ekbom; Eric S Edell; Jan L Kasperbauer; David G Lott; Donald T Donovan; C Gaelyn Garrett; Guri Sandhu; James J Daniero; James L Netterville; Josh S Schindler; Marshall E Smith; Paul C Bryson; Robert R Lorenz; David O Francis
Journal:  BMJ Open       Date:  2018-04-10       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.